Brian Posner

Operates as an open-ended investment fund

Acts as Open-End Investment Fund/Unit Trust

Functions as a College/University

ClearBridge Investments is a global equity manager that seeks to deliver long-term results through authentic active management by offering investment solutions that emphasize differentiated, bottom-up stock selection. The firm offers strategies focused on three primary client objectives: high active share, income solutions and low volatility. ClearBridge Investments performs research on an ongoing basis for the maintenance of existing investments, and to identify new investment opportunities. They integrate ESG considerations into their fundamental research process across all strategies.

Biogen Idec New Ventures' strategy is to select investments in companies developing innovative human therapeutic products or technologies that will drive product discovery and development more efficiently. Their specific areas of interest are companies in Biogen Idec's current therapeutic areas of neurology, oncology and immunology/inflammation, but they also seek opportunities outside these areas that fit their strategies for longer-term growth. The firm invests at all stages of development; most of their investments are in early-stage companies. They also look for investment opportunities where they can leverage their parent's resources and scientific and development expertise to support these investments.

Discovers, develops, manufactures and supplies pharmaceutical products

Functions as a College/University

Operates as a biotechnology company that engages in discovery, research, development and commercialization of therapies for hemophilia & blood disorders

Develops therapeutics to treat muscle diseases

Provides research services to scientific discoveries